JPRN-UMIN000050343RecruitingUnknown
Efficacy and Safety of sofosbuvir/velpatasvir for HCV infected patients with decompensated LC - Efficacy and Safety of sofosbuvir/velpatasvir
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Sponsor
- Hokkaido University Hospital
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1 patients judged to be inappropriate to participate in the study by the attending physician 2 patients judged to be inappropriate to participate in the study by the primary physician
Investigators
Similar Trials
Completed
Not Applicable
Efficacy and safety of sofosbuvir/belpatasvir combination tablets for patients infected with pan-genotypic hepatitis C virusChronic liver disease infected with HCVJPRN-UMIN000035625Saitama Medical University35
Recruiting
Not Applicable
Evaluation of the efficacy of sofosbuvir/velpatasvir and ribavirin in Japanese hepatitis C patients who failed direct-acting antiviral agents: a prospective study in real life settings.cirrhotic and non cirrhotic patients with hepatitis C virusJPRN-UMIN000035713Toranomon Hospital150
Recruiting
Phase 2
Efficacy and safety of Sofosbuvir in the treatment of SARS-CoV-2: An Open Label phase II TrialSARS-CoV-2 ?associated SARI.SARS-CoV-2U07.1IRCT20200328046882N1Shahid Beheshti University of Medical Sciences60
Recruiting
Phase 2
Efficacy & Safety of Sofosbuvir/Daclatasvir treatment in COVID-19: A randomized, controlled studyCOVID-19SARS-nCoV-2 infectionDRKS00022203PHARCO CORPORATE90
Unknown
Phase 3
Role of anti Hepatitis C drug (Sofosbuvir and Ribavirin)in Liver disease.CTRI/2017/11/010373ATCO PHARMACEUTICALS62